Platelet aggregation inhibitors in primary and secondary prevention of ischemic stroke

BACKGROUND: The ischaemic stroke (IS) is one of the most frequent cause of death in Germany. Besides of non-drug many drug-based interventions are used in primary or secondary prevention of IS, among them the thrombocyte aggregation inhibitors (TAI). OBJECTIVES: The evaluation addresses the question...

Descripción completa

Detalles Bibliográficos
Autores principales: Gorenoi, Vitali, Kulp, Werner, Greiner, Wolfgang, von der Schulenburg, Johann-Matthias
Formato: Texto
Lenguaje:English
Publicado: German Medical Science 2006
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3011360/
https://www.ncbi.nlm.nih.gov/pubmed/21289960

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3011360/
https://www.ncbi.nlm.nih.gov/pubmed/21289960

Ejemplares similares